Clinical Trial Update: Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 trial evaluating the broader efficacy of atomoxetine for treating Attention Deficit Hyperactivity Disorder in chi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED